Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-11-14
2006-11-14
Smith, Lynette R. F. (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C435S007200, C435S007210, C435S007710, C435S007910, C435S021000, C435S041000, C435S183000, C435S325000, C436S002000, C436S086000, C436S174000, C436S504000
Reexamination Certificate
active
07135298
ABSTRACT:
The present invention provides an assay for the identification of agents which can modulate TOR-mediated phosphorylation of substrate proteins. The assays of the invention utilize substrate proteins whose amino acid sequence contains the Ser/Thr motif recognized by TOR. Naturally occurring TOR which may be used in the methods of the invention include TOR isolated from a variety of species, particularly mammalian tissues.
REFERENCES:
patent: 5759787 (1998-06-01), Strulovici
Brunn et al. (1997). J. of Biol. Chem. vol. 272(51): 32547-32550.
Brunn et al. (1997). Science. vol. 277:99-101.
Burnett et al. (1998). P.N.A.S. vol. 95: 1432-1437.
McMahon et al. (2002). Mol. Cell Biol. vol. 22 (21): 7428-7438.
Nave et al. (1999). Biochem.J. vol. 344: 427-431.
Polakiewicz, et al.,—Opioid Receptor Activates Signaling Pathways Implicated in Cell Survival and Translational Control*, J. Biol. Chem. 273: 23534 (1998).
Powers, et al., Regulation of Ribosome Biogenesis by the Rapamycin-sensitive TOR-signaling pathway inSaccharomyces cerevisiae, Mol. Biol. Cell 10: 987 (1999).
Raught, et al,. The target of rapamycin (TOR) proteins,PNAS 98: 7037 (2001).
Sabatini, et al., Interaction of RAFT1 with Gephyrin Required for Rapamycin-Sensitive Signaling, Science 284: 1161 (1999).
Sabers CJ. et al. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. Journal of Biological Chemistry 270(2):815-22, 1995.
Schalm, Stefanie S. and John Blenis, Identification of a Conserved Motif Required for mTOR Signaling; Current Biology 2002: 632-639.
Schlam, Stefanie S. et al., TOS Motif-Mediated Raptor Binding Regulates 4E-BP1 Multisite Phosphorylation and Function; Current Biology 2003 13: 797-806.
Scheper, et al., Eukaryotic Initiation Factors-4E and -4F Stimulate 5′ cap-dependent as well as internal initiation of protein synthesis*, J. Biol. Chem. 267: 7269 (1992).
Schmelzle, et al. TOR, a central controller of cell growth, Cell 103: 253 (2000).
Schmidt, et al., The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease, EMBO J. 17: 6924 (1998).
Scott, et al., Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway, PNAS 95: 7772 (1998).
Sekulic, et al., A direct linkage between the Phosphoinositide 3-Kinase-AKT Signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells, Cancer Res. 60: 3504 (2000).
Shamji, et al., Partitioning the transcriptional program induced by rapamycin among the effectors of the Tor proteins, Curr. Biol. 10: 1574 (2000).
Shigemitsu, et al., Regulation of Translational Effectors by Amino Acid and Mammalian Target of Rapamycin Signaling Pathways, J. Biol. Chem. 274: 1058 (1999).
Sousa A.G., Van Langenhove G. and Falotico R. et al. (2001) Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 104:2007-2011.
Tibbets, Randall S. and Abraham, Robert T., PI3K-Related Kinases Roles in Cell-Cycle Regulation and DNA Damage Responses, Signaling Networks and Cell Cycle Control: The Molecular Basis of Cancer and Other Diseases Humana Press Inc. (2000).
Vlahos et al., JA Specific Inhibitor of Phosphatidylinositol 3-Kinase, 2-(4-Morpholinyl)-8-phenyl-4-benzopyran-4-one (LY294002). Biol. Chem. 269: 5241 (1994).
Welsh, et al.,Activation of Microtubule-Associated Protein Kinase (Erk) and p70 S6 Kinase by D2 Dopamine Receptors, J. Neurochem. 70: 2139 (1998).
Zhang, H., Stallock, J. P., NG, J. C., Reinhard, C. & Neufeld, T. P., Regulation of cellular growth by the Drosophila target of rapamycin dTOR, Genes Dev. 14:2712 (2000).
Abraham, R. T., and Wiederrecht, G. J. Immunopharmacology of rapamycin. Annu. Rev. Immunol. 14: 483 (1996).
Abraham, R.T. Identification of TOR Signaling Complexes: More TORC for the Cell Growth Engine. Cell 111: 9 (2002).
Arcaro et al., Biochem. J. 296: 297 (1993) Wortmannin is a potential phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-triphosphate in neutrophil responses University of Fribourg, Rue du Musee 5. CH-1700 Fribourg, Switzerland.
Barbet, N. C., Schneider, U., Heillwell, S. B., Stansfield, I., Tuite, M. F. & Hall, M. N. Mol. Biol. Cell 7: 25 (1996) TOR Controls Translation Initiation and Early G1 Progression in Yeast (1996).
Beck, et al., The TOR signalling pathway controls nuclear localization of mutrient-regulated transcription factors, Nature (London) 402: 689 (1999).
Beretta, L., Gingras, A.-C., Svitkin, Y. V., Hall, M. N. and Sonenberg, N., Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15: 658 (1996).
Berset, et al., The TOR signal transduction pathway regulates the stability of translation initiation factor eIF4G in the yeastSaccharomyes cerevisiae, Proc. Natl. Acad. Sci. USA 95: 4264 (1998).
Blommaart, E. F., Luiken, J. J., Bloomaart, P. J., Van Woerkom, G. M. & Meijer, A. J., Phosphorylation of Ribosomal Protein S6 is inhibitory for autophagy in isolated rat hepatocytes* J. Biol. Chem. 270: 2320 (1995).
Brown, E. J., et al., A mammalian protein targeted by G=1 arresting rapamycin-receptor complex S. L. Nature (London) 369: 756 (1994).
Brunn, G. J., et al. Direct inibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15:5256 (1996).
Brunn, G. J., et al. The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH-terminus. J. Bio. Chem. 272(51):32547 (1997).
Brunn, G. J., et al.Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science. 277(5322):99 (1997).
Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H. and Sabatini, D. M. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-PB1. Proc. Natl. Acad. Sci. USA 95: 1432 (1998).
Casadio, A., Martin, K. C., Giustetto, M., Zhu, H., Chen, M., Bartsch, D., Bailey, C. H. & Kandel, E. R., A transient, neuron-wide form of CREB-Mediated long-term facilitation can be stabilized at specific synapses by local protein synthesis, Cell 99:221 (1999).
Chan, et al., A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR) PNAS USA 97: 13227 (2000).
Di Como, C. J. & Arndt, K. T. Genes Dev. 10:1904 Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases (1996).
Dumont et al., Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin, J. Immunol. 144: 251 (1990).
Essrich, et al., Postsynaptic clustering of major CABA receptor subtypes requires the 2 subunit and gephyrin, Nat. Neurosci. 1: 563 (1998).
Gingras, A. C., Raught, B., and Sonenberg, N. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15:807 (2001).
Glass, David J., Signalling pathways that mediate skeletal muscle hypertrophy and atrophy, Nature Cell Biol. 5(2):87 (2003).
Hidalgo, Manuel and Rowinsky, Eric K., The rapamycin-sensitive signal transduction pathway as a target for cancer therapy, Univ. of Texas Oncogene (2000) 19, 6680-6686.
Harris et al., The Arabidopsis Homolog of Yeast TAP42 and Mammalian 4 Binds to the catalytic subunit of protein phosphatase 2A and is induced by chilling., Plant Physiol. 121: 609(1999).
Haystead, T. A. J., Haystead, C. M. M., Hu, C., Lin, T.-A. and Lawrence, J. C. Jr. Phosphorylation of PHAS-I by mitogen-activated protein (MAP) kinase. Identification of a site phosphorylated by MAP kinase in vitro and in response to insulin in adipocytes. J. Biol. Chem.
Huang S. Houghton PJ. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Current Opinion in Investigational Drugs. 3(2):295-304, 2002.
Hudson et al., Regulation of Hypoxia-Inducible factor 1 Expression and Function by the Mammalia
Catalyst Law Group APC
Hines J.
Smith Lynette R. F.
The Burnham Institute for Medical Research
LandOfFree
Screening assay for agents that alter target of Rapamycin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening assay for agents that alter target of Rapamycin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening assay for agents that alter target of Rapamycin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3684869